Results 131 to 140 of about 2,723,375 (158)

Generation of <i>spCAS9</i> expressing human mesenchymal stem cell line to study gene function during osteoblast differentiation. [PDF]

JBMR Plus
Foessl I, Guo Y, Mies R, Kassem M, van Leeuwen JPTM, van der Eerden BCJ, Obermayer-Pietsch B, van de Peppel J.   +7 more
europepmc   +1 more source

Integrated Genetic and Biochemical Approach to Patients with Bone Disorders Exhibiting Low Alkaline Phosphatase. [PDF]

Calcif Tissue Int
Hidaka N, Kimura S, Watanabe S, Akiyama T, Tachikawa K, Michigami T, Adachi N, Irie K, Hoshino Y, Kato H, Nangaku M, Tanaka S, Makita N, Saito T, Ito N.   +14 more
europepmc   +1 more source

Biomarker-guided immunotherapy in osteosarcoma: from immune microenvironment profiling to patient stratification and combination strategies. [PDF]

Front Med (Lausanne)
Li Q.
europepmc   +1 more source

Inhibition of AXL receptor tyrosine kinase increases osteoblast function and bone mass. [PDF]

Bone Res
Ahmad M, Kölbl C, Jan I, Dorn AK, Özkan B, Olde Heuvel F, Yilmaz D, Wagner A, Vujic Spasic M, Krüger BT, Lee S, Roselli F, Ignatius A, Tuckermann J.   +13 more
europepmc   +1 more source

Hypophosphatasia and collagen VI-related muscular dystrophy presenting with gait disturbance and recurrent fractures. [PDF]

JCEM Case Rep
Im YJ, Sohn YB, Choi YJ, Jang MA, Sung DH, Chung YS.   +5 more
europepmc   +1 more source

Case Report: Atypical femoral fractures in adult-onset hypophosphatasia treated with low-dose asfotase alfa and adjunctive teriparatide therapy. [PDF]

Front Endocrinol (Lausanne)
Chung YS, Kim KK, S GB, Park JS.
europepmc   +1 more source